Oldfield Partners LLP Pfizer Inc Transaction History

Oldfield Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $1.58 Million - $2.05 Million	-48,650 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $2.32 Million - $2.65 Million	-60,400 Reduced 55.39%	48,650 $2.12 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $27,576 - $33,448	-800 Reduced 0.73%	109,050 $4.81 Million
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $907,998 - $963,417	27,300 Added 33.07%	109,850 $3.98 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $2.56 Million - $2.82 Million	82,550	82,550 $2.95 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Oldfield Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Oldfield Partners LLP with notifications on news.